Laboratory profiles of patients hospitalized with COVID-19 pneumonia treated with tofacitinib or placebo: a post hoc analysis from the STOP-COVID trial
Authors:
- Patrícia Oliveira GuimarãesPGPatrícia Oliveira Guimarães
- Lucas Petri DamianiLDLucas Petri Damiani
- Caio de Assis Moura TavaresCTCaio de Assis Moura Tavares
- Ari Stiel Radu HalpernAHAri Stiel Radu Halpern
- J. Jasper DeuringJDJ. Jasper Deuring
- Luiz Vicente RizzoLRLuiz Vicente Rizzo
- Otavio BerwangerOBOtavio Berwanger
Open Access
- 17 October 2024
- journal article
- research article
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 22, eAO0821
Abstract
Highlights Tofacitinib use did not result in meaningful changes in hematological parameters. Tofacitinib use did not lead to clinically meaningful changes in liver enzymes. ABSTRACT Objective: Tofacitinib, an oral Janus kinase inhibitor, has been tested against a placebo in 289 patients with COVID-19 pneumonia. We analyzed the data from the tofacitinib- and placebotreated patient cohorts to evaluate the laboratory profiles between baseline and day 7. Methods: We performed post hoc analyses on the following laboratory tests over time during theKeywords
This publication has 5 references indexed in Scilit:
- Characteristics of peripheral white blood cells in COVID-19 patients revealed by a retrospective cohort studyBMC Infectious Diseases, 2021
- Tofacitinib in Patients Hospitalized with Covid-19 PneumoniaNew England Journal of Medicine, 2021
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreaJAMA, 2020
- Analysis of haematological changes in tofacitinib-treated patients with rheumatoid arthritis across phase 3 and long-term extension studiesRheumatology, 2016
- Efficacy, safety and tolerability of tofacitinib in patients with an inadequate response to disease modifying anti-rheumatic drugs: a meta-analysis of randomized double-blind controlled studiesBMC Musculoskeletal Disorders, 2013